Hexa Reports Market Research Reports and Insightful Company Profiles
Global Hospital Infection Therapeutics Market Share, Size, Trends, Growth, Analysis, Outlook, Segmented Overview and Forecasts 2015-2019
Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and gastrointestinal illnesses. These infections appear between 48 hours and four days after a patient is admitted and are usually related to a treatment of procedure used to treat or diagnose the patient's initial illness or injury. Browse Detail Report With TOC @ http://www.hexareports.com/report/global-hospital-infection-therapeutics-market/details Hospital-acquired diseases are preventable through adherence to strict guidelines and less usage of invasive equipment that must be followed by healthcare professionals while caring for the patient. Antiinfective drugs are used for the treatment of these infections. These infections can be minimized by following proper infection control measures in the hospitals and healthcare institutions. Technavio's analysts forecast the global hospital infection therapeutics market to grow at a CAGR of 3.24% over the period 2014-2019.
Hexa Reports Market Research Reports and Insightful Company Profiles Covered in this report The report covers the present scenario and growth prospects of the global hospital infection therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of drugs used in the treatment of various hospital-acquired infections such as bloodstream infections, Clostridium difficile infections, hospital-acquired pneumonia, surgical site infections, and urinary tract infections. Technavio's report, Global Hospital Infection Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hospital infection therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Market driver Development of multidrug resistant variants For a full, detailed list, view our report Key Market challenge Rise in number of infection control programs For a full, detailed list, view our report Key market trend Patient assistance programs For a full, detailed list, view our report Request A Sample copy of This Report @ http://www.hexareports.com/sample/57556 Key question answered in this report 1. 2. 3. 4. 5. 6. 7.
What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Table Of Content PART 01: Executive summary Highlights
Hexa Reports Market Research Reports and Insightful Company Profiles PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights Browse All Pharmaceutical Market Research Related Reports @ http://www.hexareports.com/category/pharmaceutical-market PART 05: Disease overview Understanding disease Modes of transmission Types of infections Prevention Treatment Epidemiology Economic burden PART 06: Pipeline analysis PART 07: Market landscape Market overview Market size and forecast Five forces analysis PART 08: Market segmentation by drug class Antibacterials Antiviral drugs Antifungal drugs PART 09: Market segmentation by type of infections Urinary tract infections Respiratory tract infections Bloodstream infections Surgical site infections Gastrointestinal infections PART 10: Geographical segmentation Segmentation of global hospital infection therapeutics market by geography
Hexa Reports Market Research Reports and Insightful Company Profiles PART 11: Market drivers Development of multidrug resistant variants Rise in public health awareness Special regulatory designation for pipeline molecules Increase in number of surgical procedures PART 12: Impact of drivers Rise in number of infection control programs Increased use of generics Lack of proper healthcare infrastructure PART 13: Market challenges PART 14: Market trends PART 15: Vendor landscape Competitive scenario Market share analysis 2014 Other prominent vendors Browse Full Report @ http://www.hexareports.com/report/global-hospital-infection-therapeutics-market/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Visit our Blog: http://hexareports.blogspot.com/